Napalm Napalm Napalm is an incendiary mixture of a gelling agent and a volatile petrochemical (usually gasoline (petrol) or diesel fuel). The title is a portmanteau of the names of two of the constituents of the original thickening and gelling agents: co-precipitated aluminium salts of naphthenic and palmitic acids. Napalm B is the more modern version of napalm (utilizing styrene derivatives) and, although distinctly different in its chemical composition, is often referred to simply as "napalm". Napalm was originally developed in 1942 in a secret laboratory at Harvard University, by a team led by chemist Louis Fieser under the United States
Palmitic acid of schizophrenia, has been synthesized using the oily palmitate ester as a long-acting release carrier medium when injected intramuscularly. The underlying method of drug delivery is similar to that used with decanoic acid to deliver long-acting depot medication, in particular, neuroleptics such as haloperidol decanoate. According to the World Health Organization, evidence is "convincing" that consumption of palmitic acid increases the risk of developing cardiovascular disease, based on studies indicating that it may increase LDL levels in the blood. Retinyl palmitate is a source of vitamin A added to low fat milk to replace the vitamin content lost through the